Cindy K Miranti
Overview
Explore the profile of Cindy K Miranti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
2948
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang L, Khawaja H, Tahsin S, Clarkson T, Miranti C, Zohar Y
Front Bioeng Biotechnol
. 2024 Nov;
12:1520130.
PMID: 39600890
[This corrects the article DOI: 10.3389/fbioe.2024.1302223.].
2.
Tahsin S, Sane N, Cernyar B, Jiang L, Zohar Y, Lee B, et al.
Oncogene
. 2024 Nov;
44(1):50.
PMID: 39511413
No abstract available.
3.
Szewczyk K, Jiang L, Khawaja H, Miranti C, Zohar Y
Micromachines (Basel)
. 2024 Oct;
15(10).
PMID: 39459070
Prostate cancer is a disease in which cells in the prostate, a gland in the male reproductive system below the bladder, grow out of control and, among men, it is...
4.
Tahsin S, Sane N, Cernyar B, Jiang L, Zohar Y, Lee B, et al.
Oncogene
. 2024 May;
43(27):2092-2103.
PMID: 38769192
Androgen Receptor (AR) activity in prostate stroma is required to maintain prostate homeostasis. This is mediated through androgen-dependent induction and secretion of morphogenic factors that drive epithelial cell differentiation. However,...
5.
Jiang L, Khawaja H, Tahsin S, Clarkson T, Miranti C, Zohar Y
Front Bioeng Biotechnol
. 2024 Feb;
12:1302223.
PMID: 38322789
Lack of adequate models significantly hinders advances in prostate cancer treatment, where resistance to androgen-deprivation therapies and bone metastasis remain as major challenges. Current models fail to faithfully mimic the...
6.
Hahn A, Siddiqui B, Leo J, Dondossola E, Basham K, Miranti C, et al.
Endocrinology
. 2023 May;
164(6).
PMID: 37192413
Given the central role of the androgen receptor (AR) in prostate cancer cell biology, AR-targeted therapies have been the backbone of prostate cancer treatment for over 50 years. New data...
7.
Jensen C, Clements A, Liou H, Ball L, Bethard J, Langlais P, et al.
J Cell Biol
. 2023 Apr;
222(6).
PMID: 37042842
Distinguishing key factors that drive the switch from indolent to invasive disease will make a significant impact on guiding the treatment of prostate cancer (PCa) patients. Here, we identify a...
8.
Casillas A, Chauhan S, Toth R, Sainz A, Clements A, Jensen C, et al.
Oncogene
. 2021 Jul;
40(32):5142-5152.
PMID: 34211090
Angiogenesis is essential for the sustained growth of solid tumors. Hypoxia-inducible factor 1 (HIF-1) is a master regulator of angiogenesis and constitutive activation of HIF-1 is frequently observed in human...
9.
Staquicini D, Barbu E, Zemans R, Dray B, Staquicini F, Dogra P, et al.
Med
. 2021 Apr;
2(3):321-342.
PMID: 33870243
Background: The extensive alveolar capillary network of the lungs is an attractive route for administration of several agents. One key functional attribute is the rapid onset of systemic action due...
10.
Miranti C, Moore S, Kim Y, Chappeta V, Wu K, De B, et al.
Oncotarget
. 2020 Jul;
11(26):2586.
PMID: 32655842
[This corrects the article DOI: 10.18632/oncotarget.27589.].